Adlai Nortye, which chose the New Jersey Economic Development Authority’s New Jersey Bioscience Center – Step-Out Labs at North Brunswick as its national headquarters last year, has since experienced exponential growth, it said.
The China-based biopharmaceutical company was one of the first tenants to move into the facility shortly after it opened in June 2018.
Since moving there last August, Adlai Nortye has grown from one employee to 18 workers in New Jersey.
Lars Birgerson, CEO and president of Adlai Nortye USA, said that the company’s decision to run its U.S. operations in the state was based on three factors: access to the world’s 20 largest pharmaceutical companies; New Jersey’s talented workforce; and the state’s focus on fostering the biotechnology industry.
“We’ve been fortunate to experience exponential growth and attribute it, in large part, to New Jersey’s pharmaceutical infrastructure and its culture of innovation, which stems from Governor Murphy’s commitment to supporting early-stage companies like ours,” Birgerson said. “Additionally, the state-of-the-art equipment at the Step-Out Labs, combined with the proximity to top universities such as Rutgers and Princeton, puts us at a great advantage as we seek to advance our products.”
The Step-Out Labs at North Brunswick provides a life sciences workspace for post-incubation and emerging biopharmaceutical companies. It is located within the state’s “Bioscience Cluster” between Rutgers University and Princeton University.
“New Jersey has a long history as home to pharma, with so much to offer international pharmaceutical companies expanding into the United States,” NJEDA CEO Tim Sullivan said. “Businesses like Adlai Nortye are benefitting from the many advantages New Jersey has to offer including our state’s prime location, first-rate amenities, and impressive talent pool – all of which provide a solid foundation for the continued growth of this critical sector, which is key to Governor Phil Murphy’s vision to reclaim New Jersey’s role as a leader in innovation.”
